tiprankstipranks
Trending News
More News >
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market
Advertisement

Xeris Pharmaceuticals (XERS) Cash flow

Compare
1,007 Followers

Xeris Pharmaceuticals Cash Flow

XERS's free cash flow for Q1 2025 was $-10.04M. For the 2025 fiscal year, XERS's free cash flow was decreased by $11.44M and operating cash flow was $-10.03M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 23Dec 23Dec 23
Operating Cash Flow
$ -36.98M$ -47.02M$ -47.02M$ -47.02M$ -47.02M
Investing Cash Flow
$ 4.88M$ -6.00M$ -6.00M$ -6.00M$ -6.00M
Financing Cash Flow
$ 36.17M$ -1.61M$ -1.61M$ -1.61M$ -1.61M
End Cash Position
$ 75.74M$ 71.67M$ 71.67M$ 71.67M$ 71.67M
Free Cash Flow
$ -37.85M$ -49.29M$ -49.29M$ -49.29M$ -49.29M
Currency in USD

Xeris Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis